Tanvex BioPharma, Inc. (TPE:6541)
Taiwan · Delayed Price · Currency is TWD 41.90
+0.60 (1.45%)
Apr 2, 2026, 1:30 PM CST
-34.12% (1Y)
| Market Cap | 11.10B -37.9% |
| Revenue (ttm) | 400.97M +1,056.3% |
| Net Income | -1.50B |
| EPS | -6.13 |
| Shares Out | 264.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 465,235 |
| Average Volume | 417,882 |
| Open | 41.35 |
| Previous Close | 41.30 |
| Day's Range | 41.35 - 42.95 |
| 52-Week Range | 39.90 - 68.00 |
| Beta | 0.05 |
| RSI | 42.35 |
| Earnings Date | Apr 9, 2026 |